MIT dataset expansion quantities and Proportions. حسب Chao Tang (10925)

Experimental hardware and software environment. حسب Chao Tang (10925)

PCA-CGAN K-fold experiment table. حسب Chao Tang (10925)

Classification model parameter settings. حسب Chao Tang (10925)

MIT-BIH expanded dataset proportion chart. حسب Chao Tang (10925)

AUROC Graphs of RF Model and ResNet. حسب Chao Tang (10925)

PCA-CGAN Model Workflow Diagram. حسب Chao Tang (10925)

Structural Diagrams of RF Model and ResNet Model. حسب Chao Tang (10925)

PCA-CGAN model convergence curve. حسب Chao Tang (10925)

PCA-CGAN Structure Diagram. حسب Chao Tang (10925)

Comparison of Model Five-classification Results. حسب Chao Tang (10925)

PCAECG-GAN K-fold experiment table. حسب Chao Tang (10925)

PCA-CGAN Pseudocode Table. حسب Chao Tang (10925)

PCA-CGAN Ablation Experiment Results. حسب Chao Tang (10925)

Supporting datasets for all figures. حسب Matthew Drill (22258391)

"…Inhibition of P2X7R with small molecule antagonist AZ10606120, for 72 hours significantly decreased U251 cell number (p < 0.0001), and significantly increased tumour cell death, as evidenced by increased LDH release (p < 0.001). …"

Data Sheet 1_Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes.pdf حسب Elena Campione (8906858)

"…Finally, improvements in clinical scores i.e., PASI, NAPSI, DLQI, itch VAS, PAIN VAS, scPGA and sPGA-G and biochemical serum profile, as well as a significant decrease in serum IL-17A, TGF-β 1 and IL-10 levels (from 8.51 to 4.16 pg/mL; from 66.10 to 48.70 ng/mL and from 20.05 to 14 pg/mL, respectively) were observed in all patients.…"

Table 2_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx حسب Roberta Belli (6939221)

"…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …"

Table 1_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx حسب Roberta Belli (6939221)

"…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …"

Table 3_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx حسب Roberta Belli (6939221)

"…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …"

Image 1_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.jpg حسب Roberta Belli (6939221)

"…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …"